Heiner Niemann

Heiner Niemann

Auto-generated profile, based on publicly available information

Heiner Niemann

Clinic for Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625 Hannover, Germany

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SKStefanie Kurtz
Stefanie Kurtz
ALAndrea Lucas-Hahn
Andrea Lucas-Hahn
BSBrigitte Schlegelberger
Brigitte Schlegelberger
GGGudrun Göhring
Gudrun Göhring
HNHeiner Niemann
Heiner Niemann
Bjoern PetersenBjoern Petersen
Bjoern Petersen
Significance: The present work characterizes the porcine sex-determining region on the Y chromosome (SRY) gene and demonstrates its pivotal role in sex determination. We provide evidence that genetically male pigs with a knockout of the SRY gene undergo sex reversal of the external and internal genitalia. This discovery of SRY as the main switch for sex determination in pigs may provide an alternative for surgical castration in pig production, preventing boar taint. As the pig shares many genetic, physiological, and anatomical similarities with humans, it also provides a suitable large animal model for human sex reversal syndromes, allowing for the development of new interventions for human sex disorders.

15 November 2019 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
RHRabea Hein
Rabea Hein
HSHendrik J. Sake
Hendrik J. Sake
CPClaudia Pokoyski
Claudia Pokoyski
JHJoachim Hundrieser
Joachim Hundrieser
ABAntje Brinkmann
Antje Brinkmann
RSReinhard Schwinzer
Reinhard Schwinzer
Porcine xenografts lacking swine leukocyte antigen (SLA) class I are thought to be protected from human T cell responses. We have previously shown that SLA class I deficiency can be achieved in pigs by CRISPR/Cas9‐mediated deletion of β2‐microglobulin (B2M). Here, we characterized another line of genetically modified pigs in which targeting of the B2M locus did not result in complete absence of B2M and SLA class I but rather in significantly reduced expression levels of both molecules. Residual SLA class I was functionally inert, because no proper differentiation of the CD8+ T cell subset was observed in B2Mlow pigs. Cells from B2Mlow pigs were less capable in triggering proliferation of human peripheral blood mononuclear cells in vitro, which was mainly due to the nonresponsiveness of CD8+ T cells. Nevertheless, cytotoxic effector cells developing from unaffected cell populations (eg, CD4+ T cells, natural killer cells) lysed targets from both SLA class I+ wildtype and SLA class Ilow pigs with similar efficiency. These data indicate that the absence of SLA class I is an effective approach to prevent the activation of human CD8+ T cells during the induction phase of an anti‐xenograft response. However, cytotoxic activity of cells during the effector phase cannot be controlled by this approach.

1 July 2015 in Transplantation Direct
Verified
Journal Article
Open access
HAHellen E. Ahrens
Hellen E. Ahrens
Bjoern PetersenBjoern Petersen
Bjoern Petersen
WRWolf Ramackers
Wolf Ramackers
SPStoyan Petkov
Stoyan Petkov
DHDoris Herrmann
Doris Herrmann
HNHeiner Prof.Dr. Niemann
Heiner Prof.Dr. Niemann
Background Multiple modifications of the porcine genome are required to prevent rejection after pig-to-primate xenotransplantation. Here, we produced pigs with a knockout of the α1,3-galactosyltransferase gene (GGTA1-KO) combined with transgenic expression of the human anti-apoptotic/anti-inflammatory molecules heme oxygenase-1 and A20, and investigated their xenoprotective properties. Methods The GGTA1-KO/human heme oxygenase-1 (hHO-1)/human A20 (hA20) transgenic pigs were produced in a stepwise approach using zinc finger nuclease vectors targeting the GGTA1 gene and a Sleeping Beauty vector coding for hA20. Two piglets were analyzed by quantitative reverse-transcription polymerase chain reaction, flow cytometry, and sequencing. The biological function of the genetic modifications was tested in a 51Chromium release assay and by ex vivo kidney perfusions with human blood. Results Disruption of the GGTA1 gene by deletion of few basepairs was demonstrated in GGTA1-KO/hHO-1/hA20 transgenic pigs. The hHO-1 and hA20 mRNA expression was confirmed by quantitative reverse-transcription polymerase chain reaction. Ex vivo perfusion of 2 transgenic kidneys was feasible for the maximum experimental time of 240 minutes without symptoms of rejection. Conclusions Results indicate that GGTA1-KO/hHO-1/hA20 transgenic pigs are a promising model to alleviate rejection and ischemia-reperfusion damage in porcine xenografts and could serve as a background for further genetic modifications toward the production of a donor pig that is clinically relevant for xenotransplantation.

1 July 2009 in Animal Reproduction Science
Verified
Journal Article
Closed access
AHA. Honnens
A. Honnens
HNH. Niemann
H. Niemann
KHK. Herzog
K. Herzog
VPV. Paul
V. Paul
HMH.H.D. Meyer
H.H.D. Meyer
HBHeinrich Bollwein
Heinrich Bollwein

31 January 2012 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
Mareike BarthMareike Barth
Mareike Barth
SRSteffen Rickelt
Steffen Rickelt
ENEdeltraut Noffz
Edeltraut Noffz
SWStefanie Winter-Simanowski
Stefanie Winter-Simanowski
HNHeiner Niemann
Heiner Niemann
WFWerner Wilhelm Franke
Werner Wilhelm Franke

1 February 1994 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
CBC. Barbey
C. Barbey
JTJ. M. Tiercy
J. M. Tiercy
NFN. Fairweather
N. Fairweather
HNH. Niemann
H. Niemann
RSR. Seger
R. Seger
GCG. Corradin
G. Corradin
SUMMARY: The capacity of peripheral blood lymphocytes (PBL) or Epstein-Barr virus (EBV)-transformed B cell lines from CGD patients to process and present tetanus toxin (tt)-specific epitopes was assessed using various tt preparations and human tt-specific T cell clones. PBL from all of the donors were able to process and present either native tt and/or denatured tt to human T cell clones specific for various tt epitopes. Furthermore, no difference was found in the antigen requirement when normal or CGD EBV-B cell lines were used as antigen-presenting cells (APC). These results suggest that the deficiency in oxygen metabolism in CGD cells does not affect tt processing and presentation.